Abaxis Launches Quantitative Canine Lyme Disease Test



Published:

Abaxis Inc. added a quantitative antibody test for canine Lyme disease to its line of tests available through the Abaxis Veterinary Reference Laboratories Division in Olathe, Kan., the company reported today.

The test measures a combination of antibodies to peptides which mimic certain antigens of the Borrelia burgdorferi spirochete. The antibodies are not found in vaccinated or noninfected patients, allowing for a definitive diagnosis of the disease, according to Kenneth Aron, Ph.D., Abaxis' chief technology officer.

The test may be used as a standalone diagnostic test to determine infection status or efficacy during treatment. It also may be used as a quantitative confirmation test for Abaxis’ upcoming VetScan Lyme Rapid Test, which is under development, according to the Union City, Calif.-based company.

<HOME>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Abaxis Enjoys Huge Jump in Sales, Profit

Partnering with distributors paid off for Abaxis, while competitor Idexx saw a small revenue dip while moving to direct sales.

Tag Maker PetHub Adds Patient Records Feature

A hospital’s electronic records may be shared to help identity lost pets wearing a PetHub tag.

Do You Know a Hero Vet or Vet Tech?

The American Humane Association is accepting nominations until March 13 as part of a nationwide contest.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module